Logo image
Why Target Immune Cells for Plasma Treatment of Cancer
Journal article   Peer reviewed

Why Target Immune Cells for Plasma Treatment of Cancer

Vandana Miller, Abraham Lin and Alexander Fridman
Plasma chemistry and plasma processing, v 36(1), pp 259-268
01 Jan 2016

Abstract

Engineering Engineering, Chemical Physical Sciences Physics Physics, Applied Physics, Fluids & Plasmas Science & Technology Technology
This paper addresses the challenge of using non-equilibrium plasma as a therapeutic approach for diseases of body systems not readily accessible to plasma-generated factors. The role of plasma stimulation of the immune system is discussed as a conceivable mechanism to deliver effects. This is especially important for treatment of cancers since the pathogenesis and progression of cancers are directly influenced by immune function. By optimizing plasma parameters to induce immunogenic cell death in tumors locally, it is possible to trigger specific, protective immune responses systemically. The observations from in vitro and in vivo investigations on this subject are reviewed here. An in depth understanding of the interaction between plasma components and the cells of the immune system may provide necessary information for use of plasmas in treatment of many systemic diseases. The clinical implications of treating cancers with non-equilibrium plasma are considered. The paper also identifies some hurdles that must be overcome before plasma immunotherapy becomes a clinical reality.

Metrics

15 Record Views
117 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Engineering, Chemical
Physics, Applied
Physics, Fluids & Plasmas
Logo image